Year |
Citation |
Score |
2014 |
Dengler EC, Alberti LA, Bowman BN, Kerwin AA, Wilkerson JL, Moezzi DR, Limanovich E, Wallace JA, Milligan ED. Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain. Journal of Neuroinflammation. 11: 92. PMID 24884664 DOI: 10.1186/1742-2094-11-92 |
0.734 |
|
2013 |
Dengler EC, Liu J, Kerwin A, Torres S, Olcott CM, Bowman BN, Armijo L, Gentry K, Wilkerson J, Wallace J, Jiang X, Carnes EC, Brinker CJ, Milligan ED. Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 209-24. PMID 23517784 DOI: 10.1016/J.Jconrel.2013.03.009 |
0.725 |
|
2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Kuhn MN, Zvonok AM, Thakur GA, Makriyannis A, Milligan ED. Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain and Behavior. 2: 155-77. PMID 22574283 DOI: 10.1002/Brb3.44 |
0.743 |
|
2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Armijo LM, Kuhn MN, Thakur GA, Makriyannis A, Milligan ED. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain. 153: 1091-106. PMID 22425445 DOI: 10.1016/J.Pain.2012.02.015 |
0.758 |
|
2012 |
Wilkerson J, Alberti L, Wallace J, Kerwin A, Dengler E, Bowman B, Platero P, Thakur G, Makriyannis A, Ledent C, Milligan E. Selective cannabinoid receptor 2 (CB2R) agonist AM1710 acts independently of cannabinoid receptor 1 (CB1R) responses in neuropathic CB1R -/- mice The Journal of Pain. 13: S47. DOI: 10.1016/J.Jpain.2012.01.196 |
0.632 |
|
2010 |
Soderquist RG, Sloane EM, Loram LC, Harrison JA, Dengler EC, Johnson SM, Amer LD, Young CS, Lewis MT, Poole S, Frank MG, Watkins LR, Milligan ED, Mahoney MJ. Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration. Pharmaceutical Research. 27: 841-54. PMID 20224990 DOI: 10.1007/S11095-010-0077-Y |
0.699 |
|
2010 |
Gentry KR, Wallace JA, Dengler EC, Wilkerson JL, Candelaria GA, Norenberg JP, Milligan ED. Macrophage recruitment to the spinal cord following intrathecal injection: A mechanism to enhance gene therapy as a treatment of neuropathic pain Journal of Critical Care. 25: e17-e18. DOI: 10.1016/J.Jcrc.2010.08.022 |
0.712 |
|
2009 |
Wilkerson J, Dengler E, Thakur G, Wallace J, Zvonok A, Makriyannis A, Ashton J, Milligan E. Administration of AM 1241, a cannabinoid 2 (CB2) receptor selective agonist, to the rodent spinal cord reverses Chronic Constriction Injury (CCI) induced allodynia The Journal of Pain. 10: S22. DOI: 10.1016/J.Jpain.2009.01.095 |
0.704 |
|
Show low-probability matches. |